Literature DB >> 2480833

Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.

B Laferrere1, R J Wurtman.   

Abstract

Using in vivo microdialysis of brains of anaesthetized rats, we have examined the acute and chronic effects of D-fenfluramine on the release of serotonin (5-HT) and 5-HIAA within the frontal cortex, the lateral hypothalamus and the nucleus accumbens. A single dose of the drug (10 mg/kg) stimulated 5-HT release by 331-810% and decreased 5-hydroxyindoleacetic acid (5-HIAA) release by 30%, within all 3 brain areas. These changes were maximal 30 min after drug administration, and values returned to baseline after 120 min. Among animals receiving D-fenfluramine (3 or 10 mg/kg, i.p.) daily for 8 days and examined 24 h after the last dose, the basal release of 5-HT from frontal cortex was unaffected. However, the levels of 5-HT in this region, and its evoked release after a subsequent dose of D-fenfluramine (10 mg/kg), were significantly reduced in animals that had received the larger chronic dose. 5-HT release was restored to normal if such rats were given tryptophan (100 mg/kg, i.p.) 1 h prior to the acute D-fenfluramine dose; moreover, 5-HT release from, and levels in, frontal cortex also returned to normal without additional treatment after a 28-day washout period. These observations suggest that the chronic administration of D-fenfluramine fails to affect spontaneous 5-HT release in rat brain, and reduces the release evoked by acute D-fenfluramine only when very high doses are given. Moreover, this reduction is reversible with time or with administration of 5-HT's circulating precursor, tryptophan.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480833     DOI: 10.1016/0006-8993(89)91365-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.

Authors:  D P Holschneider; K Chen; I Seif; J C Shih
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

2.  Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats.

Authors:  M B Assié; W Koek
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.

Authors:  Matthew S Milak; Alin J Severance; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; R Todd Ogden; J John Mann; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-23       Impact factor: 6.200

4.  Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration.

Authors:  Y Wang; N Joharchi; P J Fletcher; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

5.  Regional cerebral cortical activation in monoamine oxidase A-deficient mice: differential effects of chronic versus acute elevations in serotonin and norepinephrine.

Authors:  D P Holschneider; O U Scremin; L Huynh; K Chen; I Seif; J C Shih
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  The serotonin releaser fenfluramine alters the auditory responses of inferior colliculus neurons.

Authors:  Ian C Hall; Laura M Hurley
Journal:  Hear Res       Date:  2007-01-31       Impact factor: 3.208

7.  Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.

Authors:  A J Dekker; L J Thal
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

Review 8.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

9.  Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls.

Authors:  Leo Sher; Barbara H Stanley; Thomas B Cooper; Kevin M Malone; J John Mann; Maria A Oquendo
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-30       Impact factor: 4.600

10.  p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.

Authors:  H G Series; P J Cowen; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.